Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
2.700
-0.050 (-1.82%)
At close: Jun 8, 2026, 4:00 PM EDT
2.680
-0.020 (-0.74%)
After-hours: Jun 8, 2026, 7:47 PM EDT
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $294.82 million as of June 8, 2026. Its market cap has decreased by -58.29% in one year.
Market Cap
294.82M
Enterprise Value
175.21M
1-Year Change
-58.29%
Ranking
Category
Stock Price
$2.70
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $294.82M, an increase of 209.36%. That is a compound annual growth rate of 10.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 294.80M | -22.40% |
| Dec 31, 2025 | 379.90M | -66.84% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
| Feb 18, 2015 | 95.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DiaMedica Therapeutics | 302.29M |
| Lineage Cell Therapeutics | 301.65M |
| Invivyd | 300.50M |
| Shattuck Labs | 299.05M |
| Nautilus Biotechnology | 296.09M |
| Neumora Therapeutics | 295.95M |
| Silence Therapeutics | 294.27M |
| Palisade Bio | 291.32M |